The Ecosystem Behind Innovative Vaccine Approaches
Less than 24 hours after researchers received the first genomic sequence of the novel coronavirus that causes COVID-19, scientists began working to identify potential preventative vaccines.READ MORE
Understanding mRNA Vaccines
Scientists are breaking barriers with mRNA technology, one of the approaches used to develop COVID-19 vaccines.READ MORE
What Are Monoclonal Antibodies and How Do They Work?
Scientists have discovered how monoclonal antibody treatments can help reduce the length and severity of a coronavirus infection.READ MORE
The Unique R&D Ecosystem: Delivering New Treatments and Cures to Patients
What’s the key to bringing safe, effective medicines to market? A research and development ecosystem built to take on the toughest diseases, including COVID-19 — an ecosystem that’s worth protecting.
Although they are categorized as rare, about 30 million Americans, or 10% of the population, are impacted by one of 7,000 rare diseases. America’s biopharmaceutical companies are leveraging new technologies and the growing understanding of the genetic basis for many rare diseases to develop groundbreaking therapies to meet these unmet needs.READ MORE
TELL WASHINGTON TO PROTECT INNOVATION
The United States is in a new era of medical discovery that holds unlimited promise for potential medicines targeting complex conditions, like Alzheimer’s and cancer. Make your voice heard and tell Washington we do not need to put medical innovation in jeopardy.
TOGETHER, WE FIGHT DISEASE
Nothing is possible without innovation
In Search of Targeted Treatments for Lupus
Ryan’s research gives Mitra hope that the limitations of her lupus will not last forever.LEARN MORE
I am living proof that innovation is worth it
A Lifeline for Blood Cancer
The battle against blood cancer is one that can strike early, often beginning in childhood. But thanks to the unstoppable resolve of researchers, groundbreaking treatments can now harness the body's own cells to power the fight and help give back time to patients and their families.LEARN MORE
I saw no limitations to what I could do
Pushing the boundaries of science to treat Parkinson’s disease
Biopharma researchers like Doug are fighting to give Parkinson's patients like Rich their normal lives back.LEARN MORE